Metabolic & Incretin · Research deep dive
AOD-9604: the cited literature
Every study referenced in the AOD-9604 monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, AOD-9604 is studied at 300 mcg – 600 mcg per administration, typically once daily, fasted. The reference walkthrough below maps each citation to what it actually showed.
References covered
AOD9604 and adipose tissue metabolism
Trends Endocrinol. Metab., 2001
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for AOD-9604.